Biomedical Molecular Engineering Lab
Welcome TO THE BIOMEDICAL MOLECULAR ENGINEERING
& dISEASE CONTROL LAB @ KHU
The Biomedical Molecular Engineering Laboratory designs and constructs biopharmaceutical platforms and applies them to both understand the molecular biological pathogenesis of various diseases such as cancer and inflammatory diseases and develop therapeutic strategies for them.
The lab is currently developing its own therapeutic platforms including CRISPR Self Check-In, mRNA Bridge Mimetics, EpiActivator, and EpiRepressor for curing diseases. We are currently very interested in developing biotherapuetics for treatment of various degenerative diseases.
Laboratory of Biomedical Molecular Engineering's Recent Researches
CRISPR Self Check-In for Cell-Type Specific Genome Editing
Engineered Fusion Protein for Disease Specific Genome Regulation (Shin et al. J. Immunol & Shin et al. NAR 2022)
EpiActivator & EpiRepressor for Cell Fate Control
Artifical Epigenetic Enzyme: Epigenome Engineering for Reverse Aging (Tran et al. In preparation)
Engineered Stem Cell Platform
As Interactive Therapeutic Platform
Responsive Drug Treatment for Inflammatory Disease (Kim et al. ACS AMI 2022 & Kim et al. Nano Today 2022)
Join our exciting research journey!
Research in the BMME supported by
BMME Lab
Department of Genetics and Biotechnology
Kyung Hee University
1732 Deogyeong-daero, Giheung-gu, Yongin-si, Gyeonggi-do 17104, Republic of Korea
Contact: Professor. Seung Ja Oh, Ph.D at seungja.oh@khu.ac.kr